Your browser doesn't support javascript.
loading
Enzalutamide and sleep apnea: an emerging central nervous system side-effect?
Labrize, F; Cany, L; Massard, C; Loriot, Y; Sargos, P; Gross-Goupil, M; Roubaud, G.
Afiliação
  • Labrize F; Department of Medical Oncology, Institut Bergonié, Bordeaux.
  • Cany L; Department of Medical Oncology, Clinique Francheville, Périgueux.
  • Massard C; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif.
  • Loriot Y; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif.
  • Sargos P; Department of Radiotherapy, Institut Bergonié, Bordeaux, France.
  • Gross-Goupil M; Department of Medical Oncology, Institut Bergonié, Bordeaux.
  • Roubaud G; Department of Medical Oncology, Institut Bergonié, Bordeaux g.roubaud@bordeaux.unicancer.fr.
Ann Oncol ; 27(1): 206, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26445811
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Síndromes da Apneia do Sono / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Síndromes da Apneia do Sono / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article